Overview / Abstract: |
In this clinical commentary, a panel of three faculty experts will discuss the importance of immunity assessments/titers and appropriate vaccinations for Inflammatory bowel disease (IBD) patients on immunosuppressive therapies, ACG clinical practice guidelines, strategies for improving vaccination rates, and the administrative, financial, and communication related challenges surrounding vaccines and immunity assessments for IBD patients. Because the patient plays such a critical role in shared decision-making, this activity will also include an actual patient sharing her perspectives, experiences, and treatment goals. |
Expiration |
Jun 29, 2019 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 |
Accreditation |
ACCME and CBRN |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
Ryan Ungaro, MD Sharmeel Wasan, MD Jason Worcester, MD |
Activity Specialities / Related Topics |
Primary Care, OB/GYN / Women's Health, Internal Medicine, Infectious Disease, Gastroenterology / GI, Family Medicine |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Merck & Co. |
Keywords / Search Terms |
ACHL GI, OBGYN, vaccination, IBD, irritable bowel disease, immunosuppressive therapies, ACG guidelines, infection, immunity, vaccination history, immunity assessment titers, Immunosuppressed patients, infectious agents, anti TNF therapy, vedolizumab, MMR, variceclla, herpes zoster, pneumococcal vaccine, HPV vaccine, hepatitis B vaccine, hepatitis A vaccine, rotavirus vaccine, infectious disease, Ulcerative colitis, Crohn's di |